PT  - JOURNAL ARTICLE
AU  - G H Guyatt
AU  - L B Berman
AU  - M Townsend
AU  - S O Pugsley
AU  - L W Chambers
TI  - A measure of quality of life for clinical trials in chronic lung disease.
AID  - 10.1136/thx.42.10.773
DP  - 1987 Oct 01
TA  - Thorax
PG  - 773--778
VI  - 42
IP  - 10
4099  - http://thorax.bmj.com/content/42/10/773.short
4100  - http://thorax.bmj.com/content/42/10/773.full
SO  - Thorax1987 Oct 01; 42
AB  - Since the relationships between pulmonary function, exercise capacity, and functional state or quality of life are generally weak, a self report questionnaire has been developed to determine the effect of treatment on quality of life in clinical trials. One hundred patients with chronic airflow limitation were asked how their quality of life was affected by their illness, and how important their symptoms and limitations were. The most frequent and important items were used to construct a questionnaire evaluating four dimensions: dyspnoea, fatigue, emotional function, and the patient's feeling of control over the disease (mastery). Reproducibility, tested by repeated administration to patients in a stable condition, was excellent: the coefficient of variation was less than 12% for all four dimensions. Responsiveness (sensitivity to change) was tested by administering the questionnaire to 13 patients before and after optimisation of their drug treatment and to another 28 before and after participation in a respiratory rehabilitation programme. In both cases large, statistically significant improvements in all four dimensions were noted. Changes in questionnaire score were correlated with changes in spirometric values, exercise capacity, and patients' and physicians' global ratings. Thus it has been shown that the questionnaire is precise, valid, and responsive. It can therefore serve as a useful disease specific measure of quality of life for clinical trials.